About Altos Labs
Altos Labs specializes in biotechnology with a focus on cell rejuvenation, aiming to restore cell health and resilience to reverse diseases and injuries. Their approach involves cellular rejuvenation programming, which enhances cells' ability to resist stressors that can lead to illness. Unlike competitors, Altos Labs emphasizes research and collaboration with other institutions to develop effective treatments. The company's goal is to improve patients' quality of life through breakthrough therapies.
Los Altos, CaliforniaHeadquarters
2021Year Founded
$3,180.8MTotal Funding
EARLY_VCCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees
Risks
Ethical concerns about lifespan extension may lead to regulatory challenges.
Intensifying competition in the biotechnology sector could dilute market share.
High expectations from financial backers may pressure the company to deliver quickly.
Differentiation
Altos Labs focuses on cellular rejuvenation to reverse diseases and improve health.
The company integrates computational biology and CRISPR technology for innovative solutions.
Altos Labs collaborates with leading scientists, including Nobel laureate Jennifer Doudna.
Upsides
Significant funding of $270 million supports Altos Labs' research and development efforts.
The economic potential of increased life expectancy is recognized as a major opportunity.
Collaborations with tech industry veterans accelerate innovation and commercialization.
Funding
Total raised$3.18 B
Latest valuation$15.00 B
StageEARLY_VC
EARLY VC
12/31/2021$3.0 K
$15.00 B